Stockscreener 앱 받기
2.49
13.18%
0.29
시간 외 거래:
2.47
-0.02
-0.80%
전일 마감가:
$2.20
열려 있는:
$2.23
하루 거래량:
15.19M
Relative Volume:
1.00
시가총액:
$901.02M
수익:
$241.53M
순이익/손실:
$-389.92M
주가수익비율:
-2.0244
EPS:
-1.23
순현금흐름:
$-323.54M
1주 성능:
+11.66%
1개월 성능:
-9.45%
6개월 성능:
-38.52%
1년 성능:
-76.20%
1일 변동 폭
$2.229
$2.50
1주일 범위
$2.11
$2.50
52주 변동 폭
$1.6385
$12.51
Iovance Biotherapeutics Inc Stock (IOVA) Company Profile
명칭
Iovance Biotherapeutics Inc
전화
(650) 260-7120
주소
825 INDUSTRIAL ROAD, SAN CARLOS
IOVA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IOVA
Iovance Biotherapeutics Inc
|
2.49 | 796.08M | 241.53M | -389.92M | -323.54M | -1.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Iovance Biotherapeutics Inc Stock (IOVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2025-05-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-05-12 | 다운그레이드 | Truist | Buy → Hold |
| 2025-05-09 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-10-24 | 개시 | UBS | Buy |
| 2024-07-29 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-11-20 | 개시 | Goldman | Buy |
| 2023-09-18 | 재확인 | Barclays | Overweight |
| 2023-05-30 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-03-27 | 재개 | Wells Fargo | Equal Weight |
| 2023-01-27 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-12-09 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-10-31 | 개시 | Guggenheim | Neutral |
| 2022-08-18 | 재개 | Wells Fargo | Equal Weight |
| 2022-01-28 | 업그레이드 | Stifel | Hold → Buy |
| 2021-12-07 | 재개 | Cowen | Outperform |
| 2021-06-10 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2021-05-20 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-05-19 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2021-05-19 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-05-03 | 개시 | Truist | Buy |
| 2021-04-16 | 개시 | Goldman | Buy |
| 2021-03-08 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2020-12-15 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2020-10-06 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-04-22 | 개시 | Mizuho | Buy |
| 2020-03-04 | 개시 | Barclays | Overweight |
| 2020-02-26 | 재확인 | H.C. Wainwright | Buy |
| 2020-02-26 | 재확인 | Oppenheimer | Outperform |
| 2019-12-18 | 개시 | JMP Securities | Mkt Outperform |
| 2019-10-01 | 개시 | Stifel | Buy |
| 2019-04-29 | 개시 | Piper Jaffray | Overweight |
| 2019-02-28 | 재확인 | Chardan Capital Markets | Buy |
| 2019-02-07 | 개시 | Robert W. Baird | Outperform |
| 2018-12-31 | 재개 | B. Riley FBR | Buy |
| 2018-07-06 | 재확인 | Chardan Capital Markets | Buy |
| 2018-04-10 | 업그레이드 | B. Riley FBR, Inc. | Neutral → Buy |
| 2018-03-13 | 재확인 | B. Riley FBR, Inc. | Neutral |
| 2018-02-23 | 다운그레이드 | B. Riley FBR, Inc. | Buy → Neutral |
| 2018-01-25 | 재확인 | H.C. Wainwright | Buy |
| 2017-11-01 | 재확인 | B. Riley FBR, Inc. | Buy |
모두보기
Iovance Biotherapeutics Inc 주식(IOVA)의 최신 뉴스
Iovance Biotherapeutics Secures Canadian Approval for Groundbreaking Therapy - StocksToTrade
Is Iovance Biotherapeutics Inc. benefiting from interest rate changes2025 Biggest Moves & Growth Focused Entry Point Reports - خودرو بانک
Using Bollinger Bands to evaluate Iovance Biotherapeutics Inc.Trade Ideas & Long-Term Investment Growth Plans - Newser
What institutional flow reveals about Iovance Biotherapeutics Inc.IPO Watch & Low Risk Investment Opportunities - Newser
Using economic indicators to assess Iovance Biotherapeutics Inc. potentialWeekly Trade Review & Real-Time Volume Analysis - Newser
Is this a good reentry point in Iovance Biotherapeutics Inc.Weekly Investment Report & Low Drawdown Momentum Ideas - Newser
Should I add Iovance Biotherapeutics Inc. stock to my portfolio2025 Technical Patterns & Weekly Stock Performance Updates - خودرو بانک
How to use a screener to detect Iovance Biotherapeutics Inc. breakoutsTrade Analysis Summary & Safe Entry Trade Reports - Newser
How to read the order book for Iovance Biotherapeutics Inc.July 2025 Spike Watch & Real-Time Stock Entry Alerts - Newser
Chart based analysis of Iovance Biotherapeutics Inc. trendsNew Guidance & Breakout Confirmation Trade Signals - Newser
Tools to monitor Iovance Biotherapeutics Inc. recovery probabilityEarnings Beat & AI Enhanced Trading Alerts - Newser
Is Iovance Biotherapeutics Inc. forming a bottoming baseJuly 2025 Spike Watch & Risk Controlled Daily Trade Plans - Newser
Does Iovance Biotherapeutics Inc. qualify in momentum factor screeningAnalyst Upgrade & Safe Investment Capital Preservation Plans - Newser
Key resistance and support levels for Iovance Biotherapeutics Inc.Trade Analysis Report & Weekly Momentum Picks - Newser
Reversal indicators forming on Iovance Biotherapeutics Inc. stockTrade Risk Summary & Consistent Return Strategy Ideas - Newser
Artisan Small Cap Fund Exited Its Stake in Iovance Biotherapeutics (IOVA) Due to Operational Challenges - MSN
Short Term Charts Align With Long Term Uptrend in Iovance Biotherapeutics Inc.July 2025 Recap & Free Weekly Watchlist of Top Performers - beatles.ru
Is Iovance Biotherapeutics Inc. forming a bullish divergenceWeekly Trend Recap & Weekly Watchlist for Hot Stocks - خودرو بانک
Risk adjusted return profile for Iovance Biotherapeutics Inc. analyzedQuarterly Market Summary & Daily Oversold Stock Bounce Ideas - Newser
Iovance Biotherapeutics shares rise 1.32% premarket after Immunome's presentation at H.C. Wainwright conference. - AInvest
Can machine learning forecast Iovance Biotherapeutics Inc. recovery2025 Breakouts & Breakdowns & Free Long-Term Investment Growth Plans - Newser
Multi asset correlation models including Iovance Biotherapeutics Inc.July 2025 Trends & Momentum Based Trading Ideas - Newser
How to recover losses in Iovance Biotherapeutics Inc. stockMarket Volume Summary & Safe Capital Growth Trade Ideas - Newser
Custom watchlist performance reports with Iovance Biotherapeutics Inc.Weekly Trend Report & Intraday High Probability Setup Alerts - Newser
Chart overlay techniques for tracking Iovance Biotherapeutics Inc.Earnings Recap Summary & High Conviction Buy Zone Picks - Newser
Is Iovance Biotherapeutics Inc. stock bottoming outPortfolio Risk Summary & Long-Term Safe Investment Plans - Newser
Valuation Update: Is Iovance Biotherapeutics Inc. benefiting from interest rate changesMarket Performance Summary & Risk Controlled Stock Pick Alerts - خودرو بانک
What to expect from Iovance Biotherapeutics Inc. in the next 30 daysMarket Risk Report & Long-Term Growth Stock Strategies - Newser
Published on: 2025-09-01 23:03:51 - Newser
Real time social sentiment graph for Iovance Biotherapeutics Inc.Market Rally & Safe Entry Trade Reports - Newser
Building trade automation scripts for Iovance Biotherapeutics Inc.2025 Trading Recap & Daily Profit Maximizing Tips - Newser
Will Iovance Biotherapeutics Inc. bounce back from current supportMarket Performance Report & Fast Moving Stock Watchlists - Newser
Detecting support and resistance levels for Iovance Biotherapeutics Inc.Earnings Growth Report & Verified Technical Signals - Newser
Intraday pattern recognizer results for Iovance Biotherapeutics Inc.Market Performance Recap & Stock Portfolio Risk Management - Newser
Will Iovance Biotherapeutics Inc. benefit from macro trendsEarnings Recap Summary & Reliable Entry Point Trade Alerts - Newser
Can momentum traders help lift Iovance Biotherapeutics Inc.Gap Up & Breakout Confirmation Trade Signals - Newser
Will Iovance Biotherapeutics Inc. continue its uptrendPortfolio Return Report & Fast Gain Stock Trading Tips - Newser
Iovance Biotherapeutics Inc (IOVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):